Registration

Welcome Address

Speakers' Introduction & Memento Presentation

Card Exchange and Networking Session

Coffee Break and Networking in Exhibition Area

Yesterday, Today and Tomorrow of Antibody
Manjula Das, Principal Investigator, Mazumdar Shaw Center for Translational Research (MSCTR), India

Q/A Discussion

Q/A Discussion

Antibody Engineering in Biotherapeutic Development
Ashvini Kumar Dubey, Senior Scientist, Zumutor Biologics, India

Q/A Discussion

AbTids - A New Class of Antimicrobials
Sanjiban K Banerjee, Director, AbGenics Lifesciences Pvt Ltd, India

Q/A Discussion

Antibody Engineering Approach for High Quality Clone & Process Development
Shailja Dwivedi, Sr. Research Executive- Advanced Biotech Lab, Ipca Laboratories Ltd, India

Q/A Discussion

Group Photograph Session

Lunch Break and Networking in Exhibition Area

Development of Site-Specific Steroid-ADC for the Treatment of Inflammatory Diseases
Amy Han, Director, Chemistry, Regeneron Pharmaceuticals, United States of America

Q/A Discussion

Next Generation Antibody Drug Conjugates (ADCs): Firing Magical Bullets Continues
Syeda Warisul Fatima, Research Scholar, Indian Institute of Technology Delhi, India

Q/A Discussion

Coffee Break and Networking in Exhibition Area

Q/A Discussion

Conference Feedback

End of First Day of Conference

Introduction to Technical Session

Developing Validated Assays for Biomarkers and Antibody Drug Conjugates
Kalpesh Jain, Founder and Technical Head, KRISHGEN Biosystems

Q/A Discussion

Technology Spotlight:
Glimpses of Solutions and Portfolio for Advanced Applications
Ashish Pargaonkar, Field Applications Specialist - Biopharma, Agilent Technologies India Pvt Ltd.

Technology Spotlight:
iQue® Plus - Unique Among Flow-Cytometers
Suyog Jakhadi, Product Manager- Bio-Analytics & Liquid Handling Products, Sartorius

Technology Spotlight:
Antibody Engineering reducing Antibody Dilemma in Biomarkers Study
Rashmi Upadhyay, Head- Sales & Marketing, GeNext Genomics Pvt Ltd

Coffee Break and Networking in Exhibition Area

Steps in Designing an ADC
Priyaranjan Pattanaik, Associate Research Director, Syngene International Ltd

Q/A Discussion

A Streamlined Drug-to-Antibody Ratio Determination Workflow for Intact and Deglycosylated Antibody-Drug Conjugates
Ashish Pargaonkar, Field Applications Specialist - Biopharma, Agilent Technologies India Pvt Ltd., India

Q/A Discussion

Interactive Session
This is going to be a special designed interactive session wherein, the delegates will get an excellent opportunity to interact with the renowned experts/speakers in an informal open discussion giving them a chance to put up queries and get solutions.

Lunch Break and Networking in Exhibition Area

Q/A Discussion

The Curious Case of T-DM1 – First Antibody Drug Conjugate for HER2 Positive Breast Cancer
Jagdish Nigade, Group Medical Manager, Roche, India

Q/A Discussion

Coffee Break and Networking in Exhibition Area

Q/A Discussion

Conference Feedback

Closing Remarks and Vote of Thanks

End of Conference